Acute Myeloid Leukemia Research

17 researchers across 5 institutions

17 Researchers
5 Institutions
2 Grant PIs
6 High Impact

Researchers investigate the fundamental biological mechanisms underlying acute myeloid leukemia (AML). This work includes studying the genetic and epigenetic alterations that drive leukemia development and progression, exploring the role of the bone marrow microenvironment, and analyzing the molecular pathways involved in cancer cell survival and resistance to therapy. Investigations utilize a range of approaches, from cell culture and animal models to advanced genomic and proteomic analyses. Specific areas of focus include identifying novel therapeutic targets and understanding the biological basis of treatment response and relapse.

Given the significant burden of hematologic malignancies in Arkansas, AML research holds direct relevance for improving public health outcomes. Understanding the specific genetic landscape of AML in diverse populations within the state can inform targeted prevention and treatment strategies. Furthermore, advancements in AML research can foster collaborations with the state's biotechnology and pharmaceutical sectors, contributing to economic development and the creation of specialized healthcare jobs.

This research area draws upon expertise in molecular biology, genetics, immunology, and pharmacology. Engagement across multiple Arkansas institutions facilitates a comprehensive approach to understanding and combating AML, connecting basic science discoveries with potential clinical applications and public health initiatives.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Peter Anthony Crooks UAMS 57 15,023 ARA High Impact
David L. Becton UAMS 28 2,960 High Impact
Jingwen Li University of Arkansas 28 2,847
Kimo C. Stine UAMS 27 2,469 High Impact
Jason E. Farrar UAMS 25 3,223 Faculty High Impact Grants
Thomas E. Goodwin Hendrix College 22 1,495 High Impact
Samrat Roy Choudhury UAMS 20 1,565 Faculty High Impact
Youzhong Yuan UAMS 20 2,455
Anita A. Joshi UAMS 13 1,522
Cristyn N. Branstetter UAMS 3 325
Mouad Abdulrahim Hendrix College 3 28
Basharath Khan Arkansas State University 2 5
Giselle Almeida Gonzalez UAMS 1 5
Arundhati Chavan UAMS 1 2 Graduate Student
Rija T. Ahmed 1 2
Keerthi Sripathi Arkansas Colleges of Health Education 1 2
Hong-yu Li UAMS 0 0 ARA Grant PI

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
1 works in 2035
-41.8% CAGR 2018–2035
Leadership concentration
9.4% held by global top 5 institutions
Fragmented HHI 50
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2035 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 10,634
  2. 2 Dana-Farber Cancer Institute 4,833
  3. 3 Harvard University 4,534
  4. 4 Memorial Sloan Kettering Cancer Center 4,415
  5. 5 Mayo Clinic 3,979

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Acute Myeloid Leukemia Research.

39%
Mouad Abdulrahim Hendrix College
36%
Keerthi Sripathi Arkansas Colleges of Health Education

Researchers with Federal Grants

Browse All 17 Researchers in Directory